Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is a leader in non-invasive CAD diagnosis with strong revenue growth potential, high gross margins, and potential to expand their TAM with AI-powered software capabilities. However, competition and risks such as the ongoing DOJ investigation could impact the company's financials and target price, which currently applies a 15.0x multiple to a projected 2026 revenue of $210.5 million. Further information is needed to fully assess the potential impact of the DOJ investigation on HeartFlow's financials and determine the likelihood of a settlement.

Bears say

HeartFlow is a medical technology company that offers innovative software and artificial intelligence solutions for the diagnosis and management of coronary artery disease. While the company has shown promising growth and technological advancements, its high debt and one-time non-cash charge associated with its IPO are concerning factors. Additionally, the market for CAD solutions is highly competitive, and it remains to be seen how well HeartFlow's technology will hold up against its rivals.

HeartFlow Inc (HTFL) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 5 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.